BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


SEARCH JOBS










 Company News
ThromboGenics NV (TBGNF)' JETREA Receives Positive Recommendation From Scottish Medicines Consortium (SMC) 8/11/2014 10:53:02 AM
ThromboGenics NV (TBGNF)' JETREA Nominated For 2014 Prix Galien USA 7/31/2014 10:49:20 AM
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014 5:57:48 AM
Novartis AG (NVS), Shire Weighing $1.3 Billion Offer For ThromboGenics NV (TBGNF) 4/15/2014 8:02:48 AM
Flailing ThromboGenics NV (TBGNF) Considering Strategic Options 2/24/2014 8:04:47 AM
ThromboGenics NV (TBGNF)' Founder Prof Desire Collen Retiring As Chairman 12/9/2013 6:51:51 AM
ThromboGenics NV (TBGNF)' JETREA® Nominated for 2013 Prix Galien USA 10/21/2013 8:12:43 AM
Germany's G-BA Confirms That ThromboGenics NV (TBGNF)' JETREA® Demonstrates Significant Therapeutic Benefits for Vitreomacular Traction (VMT) Patients, Including When Associated With Macular Hole 10/18/2013 9:37:51 AM
ThromboGenics NV (TBGNF) Establishes Level 1 ADR Program for US Investors 9/30/2013 8:34:09 AM
ThromboGenics NV (TBGNF) Grabs Exclusive Rights to Bicycle Therapeutics Limited's Eye Treatment Technology 9/5/2013 7:12:11 AM
123456